7-甲氧基-1-苯并呋喃-2(3H)-酮 | 28033-41-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并呋喃
• 中文名称: 7-甲氧基-1-苯并呋喃-2(3H)-酮
• 中文别名: 苯甲酸,4-(苯基甲氧基)-,2-羟基-3-(1,2,3,6-四氢-1,3-二甲基-2,6-二羰基-7H-嘌呤-7-基)丙基酯
• 英文名称: 7-methoxy-3H-benzofuran-2-one
• 英文别名: 7-Methoxy-3H-benzofuran-2-on；7-Methoxybenzofuran-2(3H)-one；7-methoxy-3H-1-benzofuran-2-one
• CAS: 28033-41-2
• 化学式: C₉H₈O₃
• 分子量: 164.161
• InChiKey: BTOOVHBRBFRQNV-UHFFFAOYSA-N

物化性质

• 沸点：
  305.3±31.0 °C(Predicted)
• 密度：
  1.262±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  35.5
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  7-甲氧基-1-苯并呋喃-2(3H)-酮 、 异丙胺 以 苯 为溶剂， 生成 2-(2-Hydroxy-3-methoxy-phenyl)-N-isopropyl-acetamide
  参考文献：
  名称：

  DE1959898

  摘要：

  公开号：
• 作为产物：
  描述：

  2-(2,3-二甲氧基苯基)-2-羟基乙腈 在 吡啶 、 氢碘酸 、 溶剂黄146 、 乙酰氯 作用下， 生成 7-甲氧基-1-苯并呋喃-2(3H)-酮
  参考文献：
  名称：

  Mosimann; Tambor, Chemische Berichte, 1916, vol. 49, p. 1265

  摘要：

  DOI：

文献信息

• BENZOFURANYL- AND BENZOTHIENYL- PIPERAZINYL QUINOLINES AND METHODS OF THEIR USE
  申请人：Venkatesan Aranapakam Mudumbai

  公开号：US20090054454A1

  公开（公告）日：2009-02-26

  Benzofuranyl- and benzothienyl-piperzinyl quinoline derivatives and compositions containing such compounds are disclosed. Methods of using benzofuranyl- and benzothienyl-piperzinyl quinoline derivatives and compositions containing such composition in the treatment and/or prevention of serotonin-related disorders, such as depression and anxiety, are also disclosed. In addition, processes for the preparation of benzofuranyl- and benzothienyl-piperzinyl quinoline derivatives are disclosed.

  本专利揭示了苯并呋喃基和苯并噻吩基哌嗪喹啉衍生物以及含有这些化合物的组合物。还揭示了使用苯并呋喃基和苯并噻吩基哌嗪喹啉衍生物以及含有这种组合物在治疗和/或预防与5-羟色胺相关的疾病，如抑郁症和焦虑症的方法。此外，还揭示了制备苯并呋喃基和苯并噻吩基哌嗪喹啉衍生物的方法。
• [EN] ANTIDEPRESSANT PIPERIDINE DERIVATIVES OF HETEROCYCLE-FUSED BENZODIOXANS<br/>[FR] DERIVES PIPERIDINE D'HETEROCYCLE DE BENZODIOXANS FUSIONNES EN TANT QU'ANTIDEPRESSEURS
  申请人：WYETH CORP

  公开号：WO2004024733A1

  公开（公告）日：2004-03-25

  Compounds of the Formula: are useful for the treatment of depression (including but not limited to major depressive disorder, chi ldhood depression and dysthymia), anxiety, panic disorder, post-traumatic stress disorder, premenstrual dysphoric disorder (also known as premenstrual syndrome), attention deficit disorder (wit h and without hyperactivity), obsessive compulsive disorder, social anxiety disorder, generalized anxiety disorder, obesity, eating disorders such as anorexia nervosa and bulimia nervosa, vasomotor flushing, cocaine and alcohol addiction, sexual dysfunction and related illnesses.

  该公式化合物用于治疗抑郁症（包括但不限于重性抑郁障碍、儿童抑郁和忧郁症）、焦虑、恐慌障碍、创伤后应激障碍、经前期失调性障碍（也称为经前综合征）、注意力缺陷障碍（有和无多动症）、强迫症、社交焦虑障碍、广泛性焦虑障碍、肥胖症、厌食症和暴食症、血管运动性潮红、可卡因和酒精成瘾、性功能障碍及相关疾病。
• Anionic Homologous Fries Rearrangement of O-(2-Methylaryl)carbamates. A Regiospecific Route to Benzo[b]furan-2(3<i>H</i>)-ones including an Unnamed Metabolite from <i>Helenium</i> Species
  作者：A. Kalinin、M. Miah、S. Chattopadhyay、M. Tsukazaki、M. Wicki、T. Nguen、A. Coelho、M. Kerr、V. Snieckus

  DOI：10.1055/s-1997-5743

  日期：1997.7

  A new LDA mediated O → C carbamoyl migration, 3 provides a general and efficient route to aryl acetamides 5, precursors to the benzo- and naphthofuranones 7, one of which serves as a starting material for a short synthesis of naturally-occurring benzofuranolactol 11 isolated from several Helenium species.

  一种新的 LDA 介导的 O → C 氨基甲酰基迁移 3 为芳基乙酰胺 5（苯并呋喃酮和萘并呋喃酮 7 的前体）提供了一条普遍而有效的途径，其中一种芳基乙酰胺 5 可作为简短合成从几种 Helenium 植物中分离出来的天然苯并呋喃内酯 11 的起始原料。
• Antidepressant piperidine derivatives of heterocycle-fused benzodioxans
  申请人：——

  公开号：US20040147523A1

  公开（公告）日：2004-07-29

  Compounds of the Formula: 1 are useful for the treatment of depression (including but not limited to major depressive disorder, childhood depression and dysthymia), anxiety, panic disorder, post-traumatic stress disorder, premenstrual dysphoric disorder (also known as premenstrual syndrome), attention deficit disorder (with and without hyperactivity), obsessive compulsive disorder, social anxiety disorder, generalized anxiety disorder, obesity, eating disorders such as anorexia nervosa and bulimia nervosa, vasomotor flushing, cocaine and alcohol addiction, sexual dysfunction and related illnesses.

  式子为1的化合物对于治疗抑郁症（包括但不限于重度抑郁症、儿童抑郁症和慢性抑郁症）、焦虑症、恐慌症、创伤后应激障碍、经前期不良情绪障碍（也称经前综合征）、注意力缺陷障碍（有或无多动症）、强迫症、社交焦虑症、广泛性焦虑症、肥胖症、进食障碍（如厌食症和贪食症）、血管活性药物潮红、可卡因和酒精成瘾、性功能障碍及相关疾病具有治疗作用。
• Benzofuranyl-and benzothienyl-piperazinyl quinolines and methods of their use
  申请人：Venkatesan Mudumbai Aranapakam

  公开号：US20050059673A1

  公开（公告）日：2005-03-17

  Benzofuranyl- and benzothienyl-piperzinyl quinoline derivatives and compositions containing such compounds are disclosed. Methods of using benzofuranyl- and benzothienyl-piperzinyl quinoline derivatives and compositions containing such composition in the treatment and/or prevention of serotonin-related disorders, such as depression and anxiety, are also disclosed. In addition, processes for the preparation of benzofuranyl- and benzothienyl-piperzinyl quinoline derivatives are disclosed.

  本发明涉及苯并呋喃基-和苯并噻吩基-哌嗪基喹啉衍生物及含有该类化合物的组合物。本发明还涉及使用苯并呋喃基-和苯并噻吩基-哌嗪基喹啉衍生物及含有该类组合物治疗和/或预防与血清素相关的疾病，例如抑郁和焦虑。此外，还公开了制备苯并呋喃基-和苯并噻吩基-哌嗪基喹啉衍生物的方法。